Oberland Capital Management
Series B → Growth
Their stated focus (public profile)
Oberland Capital is a private investment firm focused exclusively on the global healthcare industry, providing flexible, structured financing solutions to clinical-stage and commercial-stage companies in pharmaceuticals, biotechnology, medical devices, and diagnostics. The firm specializes in non-dilutive and hybrid capital structures including royalty monetizations, revenue interest financing, royalty-backed securities, project-based financing, and traditional debt. With approximately $3.2 billion in AUM, Oberland targets investment sizes of $50–$300+ million to help partners accelerate R&D, expand commercial infrastructure, and pursue inorganic growth.
Stages: Series B → Growth
Sectors: Healthtech, Life sciences, Medtech
Check size: $50-300M+
On file: 7 partners on record · 18 companies on record
Website: oberlandcapital.com
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.